A case of niraparib PARP-Inhibitor induced Sweet Syndrome in gynecologic cancer

Nora Badiner, Cody Carter, Yevgeniya Ioffe, Linda Hong

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article number101162
JournalGynecologic Oncology Reports
Volume46
DOIs
StatePublished - Apr 2023

ASJC Scopus Subject Areas

  • Oncology
  • Obstetrics and Gynecology

Keywords

  • Adverse effects
  • Niraparib
  • Ovarian cancer
  • PARPi
  • Sweet Syndrome

Cite this